Legal Gefitinib Manuafcturer CAS 184475-35-2 Pharmaceutical Cancer Treating Raw Material

  • Model NO.: 184475-35-2
  • Customized: Non-Customized
  • Suitable for: Elderly, Adult
  • Purity: >99%
  • Mf: C9h14n4o3
  • Trademark: YC
  • Specification: ISO9001: 2008
  • HS Code: 3001909099
  • Powder: Yes
  • Certification: GMP, HSE, ISO 9001, USP, BP
  • State: Solid
  • CAS: 305-84-0
  • MW: 226.23
  • Transport Package: Foil Bag/Tin or as Your Request
  • Origin: China
 

    
    
CAS No.184475-35-2
Chemical Name:Gefitinib
SynonymsIRESSA;ZD 1839;Gefinitib;Getfitnib;Gifitinib;GEFITINIB;Ji Fei Ji;AKOS 91371;Gefitinib WS;Gefitinib, >=99%
CBNumber:CB8120056
Molecular Formula:C22H24ClFN4O3
Formula Weight:446.9

Indications and Uses
Gifitinib is an antineoplastic target therapy drug with relatively high specificity that was developed by the British pharmaceutical company AstraZeneca; it is the first molecular targeted drug to be used in non-small cell lung cancer treatment. Epidermal growth factors (EGF) are a kind of polypeptide with a relative molecular mass of 6.45x103, and they can bind with epidermal growth factor receptors (EGFR) on target cell membrane surfaces to trigger biological effects. EGFR is a type of tyrosine kinase (TK) type receptor, so when bound with EGF, it will promote TK activation in the receptor. This will cause tyrosine residue in the receptor to autophosphorylate and send continuous dividing signals into the cell, causing cell proliferation and differentiation. EGFR is abundant in human tissue, and it is highly expressed in malign tumors. Gifitinib blocks the signal transduction pathway of cell surface EGFR to prevent tumor growth, metastasis, and growth in blood vessels, and it can induce tumor cell apoptosis. Gifitinib is mainly used to treat non-stem cell lung cancer.

Pharmacokinetics
It is orally effective, with relatively slow absorption and metabolism following intake. The bioavailability of a single oral 250mg dose is nearly 60%, and its area under curve (AUC) is dependent on dosage. With single daily dosages, blood concentration is steady after 7-10 days, with blood concentration peaking 3-7 hours after medication and then gradually following biphasic reduction (its half-life is 12-58 hours, at an average of 28 hours). It is observed as dose-dependent pharmacokinetics, and following multiple dosages, AUC and Cmax increased proportionally. When taken with food, its Cmax and AUC did not decrease significantly. Its plasma protein binding rate is nearly 90%. Gifitinib is metabolized through many different pathways in the livers in a relatively complicated process; the main component of its oxidative metabolism is the cytochrome P450 enzyme CYP3A4, which mainly metabolizes O-Desmethyl metabolites. Metabolites are unrelated to the pharmacological effects of the original drug. The original drug and many metabolites are mostly passed through the biliary tract and excreted through feces, while the amount of drug excreted through urine is less than 4% the original dosage amount.

Adverse Reactions
Gifitinib is relatively well-tolerated, and most negative reactions are mild and reversible, characteristics that are vastly different from those of standard negative reactions to cytotoxic drugs. Common negative reactions include diarrhea, nausea, rashes, acne, vomiting, and feebleness. Only 1% of patients have had to cease treatment due to negative reactions with an occurrence rate over 20%. There have also been rare cases of acute interstitial pneumonia.

Warnings and precautions
Gifitinib is not suitable for pregnant women, and breastfeeding women should cease breastfeeding throughout their treatment period.

Chemical Properties
Light-Yellow Crystalline Powder

Uses
Gefitinib (Iressa, ZD-1839) is an EGFR inhibitor for Tyr1173, Tyr992, Tyr1173 and Tyr992 in the NR6wtEGFR and NR6W cells with IC50 of 37 nM, 37nM, 26 nM and 57 nM, respectively.
Gefitinib is an antineoplastic.


Our advantages:
1, High quality with competitive price:
1)Standard: Enterprise Standard
2)All Purity min 99%
3)We are manufacturer and can provide high quality products with factory price.


2, Fast and safe delivery
1)Parcel can be sent out in 24 hours after payment. Tracking number available
2)Secure and discreet shipment. Various transportation methods for your choice.
3)Customs pass rate min 99%
4) We have our own agent/remailer/distributor who can help us ship our products very fast and safe, and we have stock in there for transferring.


3, We have clients throughout the world.
1)Professional service and rich experience make customers feel at ease, adequate stock and fast delivery meet their desire.
2)Market feedback and goods feedback will be appreciated, meeting customers's requirement is our responsibility.
3) High quality, competitive price, fast delivery, first-class service gain the trust and praise from the customers.


 


Legal Gefitinib Manuafcturer CAS 184475-35-2 Pharmaceutical Cancer Treating Raw Material
Â